Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-02-04 @ 12:23 PM
Study NCT ID:
NCT01906918
Status:
UNKNOWN
Last Update Posted:
2013-11-28
First Post:
2013-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Application of Remote Ischemic Preconditioning in Patients Undergoing Open Heart Surgeries
Sponsor:
University of Campinas, Brazil
Organization:
Study Overview
Official Title:
Evaluation of Remote Preconditioning on Heart Resistance to Ischemia and Reperfusion Injury
Status:
UNKNOWN
Status Verified Date:
2013-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Strategies for myocardial protection during open heart surgeries are desired. Several experimental studies have shown beneficial effects of remote ischemic preconditioning (RIPC). The underlying mechanisms are not totally understood. This study intends to evaluate molecular mechanisms involved with RIPC on myocardium of patients underwent open heart surgeries.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: